Cargando…

Cardiovascular risk factors among people with drug-resistant tuberculosis in Uganda

BACKGROUND: Tuberculosis (TB) and its risk factors are independently associated with cardiovascular disease (CVD). We determined the prevalence and associations of CVD risk factors among people with drug-resistant tuberculosis (DRTB) in Uganda. METHODS: In this cross-sectional study, we enrolled peo...

Descripción completa

Detalles Bibliográficos
Autores principales: Baluku, Joseph Baruch, Nabwana, Martin, Nalunjogi, Joanitah, Muttamba, Winters, Mubangizi, Ivan, Nakiyingi, Lydia, Ssengooba, Willy, Olum, Ronald, Bongomin, Felix, Andia-Biraro, Irene, Worodria, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636825/
https://www.ncbi.nlm.nih.gov/pubmed/36333654
http://dx.doi.org/10.1186/s12872-022-02889-y
_version_ 1784825039979282432
author Baluku, Joseph Baruch
Nabwana, Martin
Nalunjogi, Joanitah
Muttamba, Winters
Mubangizi, Ivan
Nakiyingi, Lydia
Ssengooba, Willy
Olum, Ronald
Bongomin, Felix
Andia-Biraro, Irene
Worodria, William
author_facet Baluku, Joseph Baruch
Nabwana, Martin
Nalunjogi, Joanitah
Muttamba, Winters
Mubangizi, Ivan
Nakiyingi, Lydia
Ssengooba, Willy
Olum, Ronald
Bongomin, Felix
Andia-Biraro, Irene
Worodria, William
author_sort Baluku, Joseph Baruch
collection PubMed
description BACKGROUND: Tuberculosis (TB) and its risk factors are independently associated with cardiovascular disease (CVD). We determined the prevalence and associations of CVD risk factors among people with drug-resistant tuberculosis (DRTB) in Uganda. METHODS: In this cross-sectional study, we enrolled people with microbiologically confirmed DRTB at four treatment sites in Uganda between July to December 2021. The studied CVD risk factors were any history of cigarette smoking, diabetes mellitus (DM) hypertension, high body mass index (BMI), central obesity and dyslipidaemia. We used modified Poisson regression models with robust standard errors to determine factors independently associated with each of dyslipidaemia, hypertension, and central obesity. RESULTS: Among 212 participants, 118 (55.7%) had HIV. Overall, 196 (92.5%, 95% confidence interval (CI) 88.0-95.3) had ≥ 1 CVD risk factor. The prevalence; 95% CI of individual CVD risk factors was: dyslipidaemia (62.5%; 55.4–69.1), hypertension (40.6%; 33.8–47.9), central obesity (39.3%; 32.9–46.1), smoking (36.3%; 30.1–43.1), high BMI (8.0%; 5.0–12.8) and DM (6.5%; 3.7–11.1). Dyslipidaemia was associated with an increase in glycated haemoglobin (adjusted prevalence ratio (aPR) 1.14, 95%CI 1.06–1.22). Hypertension was associated with rural residence (aPR 1.89, 95% CI 1.14–3.14) and previous history of smoking (aPR 0.46, 95% CI 0.21–0.98). Central obesity was associated with increasing age (aPR 1.02, 95%CI 1.00–1.03), and elevated diastolic blood pressure (aPR 1.03 95%CI 1.00–1.06). CONCLUSION: There is a high prevalence of CVD risk factors among people with DRTB in Uganda, of which dyslipidaemia is the commonest. We recommend integrated services for identification and management of CVD risk factors in DRTB.
format Online
Article
Text
id pubmed-9636825
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96368252022-11-06 Cardiovascular risk factors among people with drug-resistant tuberculosis in Uganda Baluku, Joseph Baruch Nabwana, Martin Nalunjogi, Joanitah Muttamba, Winters Mubangizi, Ivan Nakiyingi, Lydia Ssengooba, Willy Olum, Ronald Bongomin, Felix Andia-Biraro, Irene Worodria, William BMC Cardiovasc Disord Research BACKGROUND: Tuberculosis (TB) and its risk factors are independently associated with cardiovascular disease (CVD). We determined the prevalence and associations of CVD risk factors among people with drug-resistant tuberculosis (DRTB) in Uganda. METHODS: In this cross-sectional study, we enrolled people with microbiologically confirmed DRTB at four treatment sites in Uganda between July to December 2021. The studied CVD risk factors were any history of cigarette smoking, diabetes mellitus (DM) hypertension, high body mass index (BMI), central obesity and dyslipidaemia. We used modified Poisson regression models with robust standard errors to determine factors independently associated with each of dyslipidaemia, hypertension, and central obesity. RESULTS: Among 212 participants, 118 (55.7%) had HIV. Overall, 196 (92.5%, 95% confidence interval (CI) 88.0-95.3) had ≥ 1 CVD risk factor. The prevalence; 95% CI of individual CVD risk factors was: dyslipidaemia (62.5%; 55.4–69.1), hypertension (40.6%; 33.8–47.9), central obesity (39.3%; 32.9–46.1), smoking (36.3%; 30.1–43.1), high BMI (8.0%; 5.0–12.8) and DM (6.5%; 3.7–11.1). Dyslipidaemia was associated with an increase in glycated haemoglobin (adjusted prevalence ratio (aPR) 1.14, 95%CI 1.06–1.22). Hypertension was associated with rural residence (aPR 1.89, 95% CI 1.14–3.14) and previous history of smoking (aPR 0.46, 95% CI 0.21–0.98). Central obesity was associated with increasing age (aPR 1.02, 95%CI 1.00–1.03), and elevated diastolic blood pressure (aPR 1.03 95%CI 1.00–1.06). CONCLUSION: There is a high prevalence of CVD risk factors among people with DRTB in Uganda, of which dyslipidaemia is the commonest. We recommend integrated services for identification and management of CVD risk factors in DRTB. BioMed Central 2022-11-04 /pmc/articles/PMC9636825/ /pubmed/36333654 http://dx.doi.org/10.1186/s12872-022-02889-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Baluku, Joseph Baruch
Nabwana, Martin
Nalunjogi, Joanitah
Muttamba, Winters
Mubangizi, Ivan
Nakiyingi, Lydia
Ssengooba, Willy
Olum, Ronald
Bongomin, Felix
Andia-Biraro, Irene
Worodria, William
Cardiovascular risk factors among people with drug-resistant tuberculosis in Uganda
title Cardiovascular risk factors among people with drug-resistant tuberculosis in Uganda
title_full Cardiovascular risk factors among people with drug-resistant tuberculosis in Uganda
title_fullStr Cardiovascular risk factors among people with drug-resistant tuberculosis in Uganda
title_full_unstemmed Cardiovascular risk factors among people with drug-resistant tuberculosis in Uganda
title_short Cardiovascular risk factors among people with drug-resistant tuberculosis in Uganda
title_sort cardiovascular risk factors among people with drug-resistant tuberculosis in uganda
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636825/
https://www.ncbi.nlm.nih.gov/pubmed/36333654
http://dx.doi.org/10.1186/s12872-022-02889-y
work_keys_str_mv AT balukujosephbaruch cardiovascularriskfactorsamongpeoplewithdrugresistanttuberculosisinuganda
AT nabwanamartin cardiovascularriskfactorsamongpeoplewithdrugresistanttuberculosisinuganda
AT nalunjogijoanitah cardiovascularriskfactorsamongpeoplewithdrugresistanttuberculosisinuganda
AT muttambawinters cardiovascularriskfactorsamongpeoplewithdrugresistanttuberculosisinuganda
AT mubangiziivan cardiovascularriskfactorsamongpeoplewithdrugresistanttuberculosisinuganda
AT nakiyingilydia cardiovascularriskfactorsamongpeoplewithdrugresistanttuberculosisinuganda
AT ssengoobawilly cardiovascularriskfactorsamongpeoplewithdrugresistanttuberculosisinuganda
AT olumronald cardiovascularriskfactorsamongpeoplewithdrugresistanttuberculosisinuganda
AT bongominfelix cardiovascularriskfactorsamongpeoplewithdrugresistanttuberculosisinuganda
AT andiabiraroirene cardiovascularriskfactorsamongpeoplewithdrugresistanttuberculosisinuganda
AT worodriawilliam cardiovascularriskfactorsamongpeoplewithdrugresistanttuberculosisinuganda